259 related articles for article (PubMed ID: 22991882)
1. Sickle cell disease: What all PAs should know.
Kayinqo G
JAAPA; 2012 Sep; 25(9):19-20. PubMed ID: 22991882
[No Abstract] [Full Text] [Related]
2. Management of sickle cell disease.
Steinberg MH
N Engl J Med; 1999 Apr; 340(13):1021-30. PubMed ID: 10099145
[No Abstract] [Full Text] [Related]
3. Pathogenesis and treatment of sickle cell disease.
Bunn HF
N Engl J Med; 1997 Sep; 337(11):762-9. PubMed ID: 9287233
[No Abstract] [Full Text] [Related]
4. New treatments of sickle cell disease.
Embury SH
West J Med; 1996 May; 164(5):444. PubMed ID: 8686307
[No Abstract] [Full Text] [Related]
5. Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
Anderson N
Pediatr Nurs; 2006; 32(6):541-3. PubMed ID: 17256291
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea for the treatment of sickle cell anemia.
Platt OS
N Engl J Med; 2008 Mar; 358(13):1362-9. PubMed ID: 18367739
[No Abstract] [Full Text] [Related]
7. Sickle cell disease in North Europe.
Howard J; Davies SC
Scand J Clin Lab Invest; 2007; 67(1):27-38. PubMed ID: 17365983
[TBL] [Abstract][Full Text] [Related]
8. Principles and indications of chronic transfusion therapy for children with sickle cell disease.
Ware R
Clin Adv Hematol Oncol; 2007 Sep; 5(9):686-8. PubMed ID: 17982409
[No Abstract] [Full Text] [Related]
9. Hydroxyurea as secondary prevention for stroke in children with sickle cell anemia.
DeBaun MR
J Pediatr; 2005 Oct; 147(4):560-1. PubMed ID: 16227052
[No Abstract] [Full Text] [Related]
10. Sickle cell patients find a brand New World.
Noonan SS
N J Med; 1999 Aug; 96(8):23-5. PubMed ID: 10457727
[TBL] [Abstract][Full Text] [Related]
11. Sickle cell disease: new insights into pathophysiology and treatment.
Inati A; Koussa S; Taher A; Perrine S
Pediatr Ann; 2008 May; 37(5):311-21. PubMed ID: 18543542
[No Abstract] [Full Text] [Related]
12. The clinical care of adult patients with sickle cell disease.
Olujohungbe A; Howard J
Br J Hosp Med (Lond); 2008 Nov; 69(11):616-9. PubMed ID: 19069260
[TBL] [Abstract][Full Text] [Related]
13. [Management of sickle cell disease].
de Montalembert M
Rev Prat; 2004 Sep; 54(14):1557-64. PubMed ID: 15558966
[TBL] [Abstract][Full Text] [Related]
14. Hydroxyurea for sickle cell anemia.
Naina HV; Harris S
N Engl J Med; 2008 Jul; 359(1):98; author reply 98-9. PubMed ID: 18596283
[No Abstract] [Full Text] [Related]
15. Hematology clinic. Sickle cell disease.
Ngo D; Steinberg M
Hematology; 2014 Jun; 19(4):244-5. PubMed ID: 24666152
[No Abstract] [Full Text] [Related]
16. Avoiding admission for afebrile pediatric sickle cell pain: pain management methods.
Dumaplin CA
J Pediatr Health Care; 2006; 20(2):115-22; quiz 123-5. PubMed ID: 16522488
[No Abstract] [Full Text] [Related]
17. Hydroxyurea and new agents for the treatment of sickle cell disease.
Rodgers GP
Clin Adv Hematol Oncol; 2004 Nov; 2(11):713-5. PubMed ID: 16163257
[No Abstract] [Full Text] [Related]
18. [Pathophysiology and treatment of sickle-cell disease].
van Beers EJ; Peters M; Biemond BJ
Ned Tijdschr Geneeskd; 2005 May; 149(21):1144-9. PubMed ID: 15940917
[TBL] [Abstract][Full Text] [Related]
19. Current and emerging treatments for sickle cell disease.
Monus T; Howell CM
JAAPA; 2019 Sep; 32(9):1-5. PubMed ID: 31460979
[TBL] [Abstract][Full Text] [Related]
20. Atrial septal defect closure on cardiopulmonary bypass in a sickle cell anemia: role of hydroxyurea and partial exchange transfusion.
Gosavi KS; Dash SK; Shah BN; Upasani CB
Ann Card Anaesth; 2010; 13(2):145-7. PubMed ID: 20442545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
